NXP2 Antibodies: What They Target, How They're Used, and What to Look For

What NXP2 Antibodies Recognize

NXP2 antibodies are immunoreagents designed to detect the NXP2 protein, also known as MJ or p140. NXP2 is a nuclear protein involved in transcriptional regulation and has been studied in the context of myositis, where autoantibodies against it are a recognized serological marker. The antibodies used in research and diagnostics are typically raised against specific epitopes of the NXP2 protein and are available as monoclonal or polyclonal formats.

Biological Role and Disease Relevance

NXP2 functions as a component of transcriptional regulatory complexes, and its expression is tightly regulated. In autoimmune disease, particularly idiopathic inflammatory myopathies, the presence of anti-NXP2 autoantibodies is associated with distinct clinical features, including more severe muscle involvement and a higher risk of malignancy in some adult populations. Research reagents that detect NXP2 help scientists study these immune responses and the protein's role in gene regulation.

Common Applications

NXP2 antibodies are used across several laboratory techniques, each suited to a different type of question. The most common applications include:

• Immunofluorescence (IF): Detects NXP2 in fixed cells and tissues, often revealing a characteristic nuclear staining pattern.
• Western blotting: Confirms the molecular weight of the NXP2 protein and assesses expression levels in different cell types or tissues.
• Immunohistochemistry (IHC): Allows visualization of NXP2 in tissue sections, useful for studying expression in muscle biopsies and tumor samples.
• ELISA and dot blotting: Applied in serological studies to detect anti-NXP2 autoantibodies in patient serum.

How to Choose a Reliable NXP2 Antibody

Selecting the right antibody depends on the intended application. Not all NXP2 antibodies perform equally well in every technique. Key factors to evaluate include:

• Validation data: Look for antibodies that come with published validation in the specific application, such as knockout controls or peptide competition data.
• Host species and clonality: Monoclonal antibodies offer specificity; polyclonal antibodies may provide stronger signal in some assays. Choose a host species that matches your secondary detection system.
• Species reactivity: Confirm that the antibody has been tested on the species you are studying — human, mouse, and rat reactivity differ.
• Catalog and clone information: Reputable suppliers list the clone name, immunogen sequence, and recommended dilutions, which helps with reproducibility.

Limitations and Practical Considerations

NXP2 antibodies can cross-react with related proteins depending on the epitope targeted, so results should be interpreted with appropriate controls. Expression levels of NXP2 can vary across tissues and cell types, which may affect signal strength. For diagnostic applications, anti-NXP2 antibody testing is typically part of a broader myositis panel, and results are best understood in the context of clinical findings rather than in isolation.

Where to Find NXP2 Antibodies

NXP2 antibodies are offered by several commercial suppliers and academic repositories. When sourcing, prioritize vendors that provide detailed product specifications, lot-to-lot consistency data, and technical support. Many researchers also consult validated antibody databases that compile user-reported performance data across applications.